Skip to main content
construction release_alert
Profile editing will be unavailable for Scholars@Duke profiles from June 11-24, 2026 as manual profile data entry transitions to Elements. More information about the transition.
cancel

Evaluating a Patient Navigation Program to Improve Therapy Management for HER2+ Metastatic Breast Cancer Patients Treated with Tucatinib

Research Grant
Duke Scholars

Administered By

Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences

Awarded By

Pfizer, Inc.

Start Date

June 20, 2025

End Date

December 31, 2026
 

Administered By

Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences

Awarded By

Pfizer, Inc.

Start Date

June 20, 2025

End Date

December 31, 2026